Canopy Growth’s latest results showcased stronger execution and renewed momentum across key markets. Is CGC stock finally ...

Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.

Enbridge offers stability, a generous dividend, and growth opportunities related to AI. Vertex Pharmaceuticals is well ...

Green Thumb Industries reported Q3 revenue above expectations and maintains positive tangible book value. Read why GTBIT ...

Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.

The provision bans online, gas station, and corner store sales of intoxicating hemp products, including delta-8, starting in ...

Top Canadian stocks such as GFL and SNDL offer significant upside potential for investors in November 2025.

Let's dive into two top Canadian pot stocks, and why these companies could have more upside than the market is granting right ...

A group of American public legal officials expressed concern about current federal law covering hemp. They feel that although it was legalized in 2018, it's only poorly defined in federal law. The ...

Haywood’s Neal Gilmer said Green Thumb’s diversified product portfolio and disciplined cost management continue to support stable performance across core markets ...